Global Leaders Watch TrumpXi Summit for Trade and Geopolitical Clues Anthropic and Microsoft in Talks for AI Chip Deal Following 5 Billion Investment TechD Cybersecuritys Total Income Surges 76 to 5325 Crore in FY26 The Federal Reserve May Be Losing Grounds for NearTerm Rate Cuts Skills Over Diplomas The Shift in EntryLevel Hiring Reshapes Talent Strategies AutoNation TJX and Alibaba in Focus as Markets Digest Mixed Sector Signals DSGR Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline EOSE Q1 2026 Earnings Narrower Loss Surprises Analysts as Energy Storage Momentum Builds FHN Q1 2026 Earnings EPS Beats Estimates as Capital Strength Shines TNGX Q1 2026 Earnings ClinicalStage Biotech Reports Slight EPS Miss Stock Slips on No Revenue Espey Mfg Electronics Corp ESP Q1 2026 Earnings EPS Surprises to the Upside with Strong Execution CRMD Q1 2026 Earnings Profit Surge Driven by NonOperating Items Revenue Remains Absent IDT Corporation IDT Edges Higher as Stock Tests Key Resistance Near 5555 Gesher Acquisition Corp II Warrants GSHRW Hold Steady at 022 Amid Quiet Trading 707 Cayman Holdings Limited JEM Sees Modest Gain Amid Narrow Trading Range Lipocine Inc LPCN Edges Higher as Biotech Stock Holds Above Key Support Energy Vault Holdings Inc NRGV Rises Nearly 2 as Investors Eye Key Resistance Monetarism Compared to Soviet Central Planning A Critical Economic Perspective RNGR Q1 2026 Earnings EPS Misses Estimates by Nearly 39 Amid Operational Headwinds Wheels Up Experience UP Drops 6 as Selling Pressure Intensifies Near Key Support TowneBank TOWN Slides Lower Testing Key Support Near 34 Ponce Financial Group PDLB Holds Steady Near Support as Sector Dynamics Unfold Floor Decor Holdings FND Edges Higher Amid Consolidation Near Resistance MasterBrand Inc MBC Surges Over 7 Resistance and Support in Focus Covenant Logistics Holds Steady Near Support Amid Mixed Market Signals WillScot Holdings WSC Edges Higher Amid Modest Gains Support and Resistance Levels in Focus Apollomics Inc Warrant APLMW Holds Steady Near Minimal Levels A Closer Look at the Biotech Derivative